Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDP-120 gel for acne vulgaris
NCT02850003Phase 1Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Jun 2016
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of IDP-120 vehicle gel in acne vulgaris, sponsored by Valeant Pharmaceuticals. Primary endpoint: Evaluators Global Severity Score at 15 Days. Started Jun 2016; status: completed.
02
Drugs
IDP-120 vehicle gel
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02850003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02850003.